In need of #Regulatory-grade EU Oncology data? Let's meet in Madrid at #EHA next month! Please reach out to learn more about our tailored reports and ECA capabilities from the leading source of European oncology data. https://ow.ly/s3Ee30sCAv2 #EHA2024 #OncologyData #RealWorldResearch #Externalcontrolarm
Scott Clymer’s Post
More Relevant Posts
-
Vice President Operations @ TriNetX Oncology GmbH ¦ Managing Director @ CancerDataNet GmbH
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/aLsR30sE7SS #EHA2024 #OncologyData #RealWorldResearch
-
-
Vice President Operations @ TriNetX Oncology GmbH ¦ Managing Director @ CancerDataNet GmbH
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/CXtg30sCE8F #EHA2024 #OncologyData #RealWorldResearch
-
-
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/rCCm30sCZRl #EHA2024 #OncologyData #RealWorldResearch
-
-
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/Xghb30sCYuX #EHA2024 #OncologyData #RealWorldResearch
-
-
#JAPAC #MarketAccess #IndianGenerics JAPAC is a market of interest, reach out to us to understand how #IQVIA can support this journey Anand Maheshwari Rahul Taneja Gaurav Pokharna Govind MK Swati Chaudhary
Join us for an in-depth webinar on the latest #FDAinitiatives, including #ProjectOptimus and Project FrontRunner, and their implications for JAPAC #biopharma. Delve into the evolving regulatory landscape, early-phase oncology, and #clinicaldevelopment strategies that are shaping global expansion. Explore oncology case studies and gain valuable insights into how these initiatives are driving innovation and excellence in the field. Don't miss this opportunity to stay ahead in the rapidly changing world of oncology. Register today: https://lnkd.in/gY4jQAp2
-
Need TA-Specific European oncology data? TriNetX Oncology can create custom, fit-for purpose reports that fit your needs. Learn more: https://ow.ly/JF7M50Rielt #OncologyData #HealthcareAnalytics #RealWorldData
-
-
What a great read on the latest changes in the EU regulatory landscape! Find out the key programs and solutions that will play a significant role in oncology research in the future: https://bit.ly/3AbktwA
-
-
On our blog, TriNetX Oncology experts explore how real-world evidence is shaping the future of regulatory pathways. Don’t miss their in-depth discussion on navigating regulatory complexities with robust #RWE strategies, transforming oncology trials with diverse and actionable data sources, and insights into the latest shifts in assessment methodologies. Learn more: https://ow.ly/LkKc50UjoKk
-
-
This will be a great opportunity to learn about Translational Drug Development (TD2)'s expansion into Europe and our commitment to accelerating #CancerTherapeuticDevelopment from #BenchToBedside. #TD2 #cancertherapeutic #clinicaltrial #clinicaldevelopment #regulatoryconsulting #TheTD2Difference
Join us this Friday at ESMO Congress 2024 in Barcelona, Spain, as TD2 brings the expertise in clinical oncology research you've been looking for! Our seasoned professionals are ready to discuss your needs around oncology clinical trial services and support. Click the link below to schedule a meeting and explore collaborative opportunities: https://hubs.ly/Q02NyNCC0 #ESMO2024 #OncologyResearch #TD2
-
-
Daiichi Sankyo to present new clinical research across its oncology portfolio at ESMO 2024, ASH 2024 and SABCS 2024 https://lnkd.in/gHgnZKYM
-